Cabot (CBT) Scheduled to Post Quarterly Earnings on Monday

Cabot (NYSE:CBTGet Free Report) will be announcing its earnings results after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of $1.47 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Cabot (NYSE:CBTGet Free Report) last issued its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.42 earnings per share for the quarter, missing analysts’ consensus estimates of $1.56 by ($0.14). The company had revenue of $968.00 million during the quarter, compared to analyst estimates of $1.09 billion. Cabot had a net margin of 7.48% and a return on equity of 25.98%. The business’s revenue for the quarter was down 15.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.73 EPS. On average, analysts expect Cabot to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Cabot Stock Performance

Shares of Cabot stock opened at $65.66 on Monday. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.17 and a quick ratio of 1.37. The firm has a market cap of $3.67 billion, a P/E ratio of 12.41, a P/E/G ratio of 2.12 and a beta of 1.29. The firm has a 50 day simple moving average of $69.25 and a 200 day simple moving average of $69.84. Cabot has a fifty-two week low of $63.73 and a fifty-two week high of $83.74.

Analyst Ratings Changes

A number of analysts recently weighed in on CBT shares. started coverage on shares of Cabot in a report on Thursday, October 5th. They issued a “buy” rating for the company. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Friday, August 11th. Finally, Credit Suisse Group lowered their target price on shares of Cabot from $85.00 to $82.00 and set an “outperform” rating for the company in a report on Tuesday, August 8th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.75.

Check Out Our Latest Research Report on CBT

Hedge Funds Weigh In On Cabot

Hedge funds and other institutional investors have recently made changes to their positions in the company. Virtu Financial LLC bought a new position in shares of Cabot during the fourth quarter worth $258,000. Engineers Gate Manager LP bought a new stake in Cabot in the 1st quarter valued at $255,000. Snowden Capital Advisors LLC lifted its position in Cabot by 5.6% in the 1st quarter. Snowden Capital Advisors LLC now owns 3,323 shares of the specialty chemicals company’s stock valued at $255,000 after acquiring an additional 176 shares in the last quarter. Cullen Capital Management LLC bought a new stake in Cabot in the 1st quarter valued at $239,000. Finally, Creative Planning bought a new stake in Cabot in the 2nd quarter valued at $236,000. 91.05% of the stock is owned by institutional investors.

Cabot Company Profile

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with's FREE daily email newsletter.